Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Following 2020's respective adjusted diluted EPS and FCF payout ratios of 77.5% and 77.1%, Altria Group's payout ratios are positioned to largely remain unchanged in 2021. While Altria Group's adjusted diluted EPS fell 1.8% YoY from Q1 2020 to Q1 2021, Altria Group beat analyst expectations by $0.02.

Altria Group: Reiterating My Buy Rating

Altria group offers a 7% dividend yield. The company has made several mistakes in the past several years.

Buy Altria For A Steady Decent Return

Altria faces risks from increasing industry regulation, their Juul investment and long-term uncertainty from tobacco's industry decline. But - Altria has a wide moat that will keep the company strong for years.

The Real Value Of Altria Stock

It's often important to look to the future when investing, and Altria's future is striving to be smoke-free. However, don't look too far or you might overlook a smokeable products business that continues to operate without much sign of slowing down.

See Through The Smoke, Altria's Smokeable Business Alone Makes It A Buy

At its current price and valuation, Altria Group (MO) represents a high risk and high return opportunity. The business faces regulatory risks surrounding the U.S. tobacco industry, litigation risks, a secular decline in demand, and as well as possible tax increases on tobacco products.

Altria Group - Perfect Setup For Long Call Option

The company posts yet another highly profitable quarter and pledges to maintain its high-yield dividend, but.

Altria's Q1: Is the Tobacco Giant All Smoke and No Flame?

Philip Morris

Altria Group has superior profit and cash flow margins, but does not have large and growing international exposure. Philip Morris has the initiative over Altria Group in smoke-free products and looks more likely to transform its revenue mix earlier.

Altria Group And Philip Morris: The Battle Of The Tobacco Dividend Heavyweights

Altria Group, Inc. (NYSE: MO) shares have advanced more than 20% since the beginning of January 2021, and the current share price stands around $49.50. Altria is a stable company with a good position in the market, while its shares could be a good choice for any investor seeking secure dividend income.

Should you buy Altria Group shares in June?

British American Tobacco

Chevron

Iron Mountain

Kinder Morgan

Lumen Technologies

MGM Growth Properties

ONEOK

Williams

So, which dividend stocks with relatively-safe high-yields should you consider? These nine remain relatively-safe income plays.

9 High-Yield Stocks With Little Risk of a Dividend Cut

Polaris

RenaissanceRe Hlds

SEI Investments

1st Source

Walgreens

The 8 Best Dividend Aristocrats You Can Buy With The Market At Record Highs

Aptiv Holdings Ltd

Concho Resources

Fiserv

Parker-Hannifin

Regeneron Pharmaceuticals

Bill Nygren (Trades, Portfolio), manager of the Oakmark Fund, disclosed this week that his firm's top six trades for the first quarter of 2021 included the closure of its positions in Aptiv PLC ( APTV , Financial) and Parker Hannifin Corp. ( PH , Financial), new stakes in Altria Group Inc. ( MO , Financial) and ConocoPhillips ( COP , Financial) and boosts to its holdings in Regeneron Pharmaceuticals Inc. ( REGN , Financial) and Fiserv Inc. ( FISV , Financial).

Bill Nygren's Top 6 Trades in the 1st Quarter

Exxon Mobil

Citigroup

Chubb

PepsiCo

Procter & Gamble

Travelers

U.S. Bancorp

Inflation has been trending higher, driven by expansionary monetary policy by central banks, pent-up demand for commodities following the Coivd-19 lockdowns, moves by companies to replenish or build up inventory, and also due to significant supply-side constraints. Now inflation appears to be here.

Stocks To Play Rising Inflation: Travelers, Exxon, U.S. Bank

American Tower

Bristol-Myers

Enbridge

Johnson & Johnson

Invesco QQQ

S&P Global

SPDR S&P 500 ETF Trust

AT&T

When someone gives you a choice: ask if you can have both? Inflation might be transitory, it might also be here to stay.

Become Inflation Proof: Buy These 4 High Quality Dividend Growth Stocks

Enterprise Products Partners

Magellan Midstream Partners

MPLX

Pembina Pipeline

Ultra-high-yielding stocks can be just what you need to fund a comfortable retirement. However, lower quality yield traps have historically not only been unreliable sources of income, they've also underperformed dependable dividend growers by 3% annually.

8 Safe Dividend Stocks Yielding Over 6%

Apple

Abbott Labs

Ameriprise Financial

Air Products and Chemicals

Cincinnati Financial

Medtronic

Microsoft

Starbucks

Total

Texas Instruments

Visa

Forecasting the income provided from a dividend growth portfolio has proven remarkably accurate, regardless of tweaks to investing philosophy. Long range predictions of an individual stock price is akin to fortune telling, yet in aggregate, the stock market increases with consistency over time.

The Perfect Predictive Power Of Dividends

AbbVie

Vanguard Value ETF

Vanguard Growth ETF

5 Most Rewarding High-Yield Income Stocks With More Upside Potential

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA HOLDS 2021 ANNUAL MEETING OF SHAREHOLDERS

Altria Holds 2021 Annual Meeting of Shareholders

Tilray Brands

TLRY stock could end up as a force in the cannabis sector, but investors' fears and hesitation and legalization remain unchanged. The post Tilray Stock Is Not Very Different Since Its Altria Merger appeared first on InvestorPlace.

Tilray Stock Is Not Very Different Since Its Altria Merger

Aflac

iShares Morningstar Multi-Asset Income ETF

VanEck Morningstar Wide Moat ETF

SPDR Portfolio S&P 500 High Dividend ETF

Given the low interest rate environment, investors look for dividend shares. Here are seven long-term stocks for retirement portfolios.

7 Best Long-Term Dividend Stocks for Your Retirement Portfolio

Kellogg

Southern Company

Tuesday's big reversal should remind investors that some of the current realities, while not totally baked in as certainties, really need to be considered when portfolio planning for the rest of 2021.

Top Wall Street Strategist Says Buy Defensive Dividend Growth for the Rest of 2021

News for Altria Stock (MO)